RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Pre...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., June 28, 2021 /PRNewswire-AsiaNet/ -- Opaganib strongly inhibits Beta (South African) and Gamma (Brazilian) COVID-19 variants, further supporting its antiviral activity Opaganib's unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatti...
Authors: LATEST ASIANET NEWS RELEASES